Federal regulators have accepted Novo Nordisk’s application to produce a pill version of its injectable weight-loss ...

Wegovy and Ozempic are both semaglutide weight loss medications, but they’re prescribed differently based on who qualifies.

Novo Nordisk is partnering with online telehealth companies to sell a direct-to-consumer, lower cost version of its popular weight-loss drug Wegovy. The pharmaceutical company announced it would be ...

One weight loss injection has been branded more effective than another, after scientists carry out the first ever ...

CVS Caremark decided to stop offering Zepbound in favor of Wegovy for weight loss. It’s the latest example of limits imposed ...

In a 72-week trial, people taking Zepbound lost 50 pounds on average, compared with about 33 pounds for people taking Wegovy.

The head-to-head examination of these weight loss drugs provides doctors with 'robust' data on their effectiveness.

Eli Lilly said on Sunday its drug Zepbound was superior to Novo Nordisk's Wegovy across five weight-loss targets such as reducing waist circumference, citing data from a head-to-head trial.

It "builds on Hims & Hers’ existing suite of weight loss solutions and provides access to all dose strengths of Wegovy in a high-quality pen for self ... Wegovy is one of several GLP-1 ...

This may increase every four weeks until you get to a maintenance dose of 2.4 milligrams. Another way Wegovy and Ozempic are slightly different is that Ozempic packets come with one injection pen.